OXIGENE THE VASCULAR TARGETING COMPANY

Oxigene, Inc.

Application Filed: 2001-08-28

Trademark Application Details

Mark For: OXIGENE THE VASCULAR TARGETING COMPANY® trademark registration is intended to cover the categories of cancer research; research and development of biopharmaceutical products, namely, vascular targeting agents and cancer therapies; and licensing of intellectual property in the field of biopharmaceutical compounds for vascular targeting agents and cancer therapies. [all]

Status

2022-08-17 UTC

DEAD REGISTRATION Cancelled Invalidated

The trademark application was registered, but subsequently it was cancelled or invalidated and removed from the registry.

Research	OneLook Acronym Finder
Serial Number	76306207
Registration Number	2893720
Mark Literal Elements	OXIGENE THE VASCULAR TARGETING COMPANY
Mark Drawing Type	1 - TYPESET WORD(S) /LETTER(S) /NUMBER(S)
Mark Type	SERVICE MARK
Standard Character Claim	No
Register	PRINCIPAL
Current Location	PUBLICATION AND ISSUE SECTION 2004-09-02
Basis	1(a)
Class Status	SECTION 8 - CANCEL
Primary US Classes	100: Miscellaneous 101: Advertising and Business
Primary International Class	042 - Primary Class (Computer, scientific & legal) Scientific and technological services and research and design relating thereto: industrial analysis and research services; design and development of computer hardware and software; legal services.
Filed Use	No
Current Use	Yes
Intent To Use	No
Filed ITU	Yes
44D Filed	No
44E Current	No
66A Current	No
Current Basis	No
No Basis	No
Cancellation Code	2
Attorney Name	Christine M. Baker
Attorney Docket Number	18217-031 [C
Law Office Assigned	L50
Employee Name	POWERS, ALEXANDER L

Timeline

2001-08-28	Application Filed
2001-08-29	Date of First Use
2002-02-01	Date of Use In Commerce
2003-04-22	Published
2003-04-22	Published for Opposition
2004-09-02	Location: PUBLICATION AND ISSUE SECTION
2004-10-12	Trademark Registered
2011-05-13	Cancelled
2011-05-13	Status: Dead/Cancelled
2011-05-13	Status: Registration cancelled because registrant did not file an acceptable declaration under Section 8. To view all documents in this
2018-07-08	Transaction Date

Trademark Parties (Applicants & Owners)

Party:	OXIGENE, INC.
Address	321 Arsenal Street Watertown, MASSACHUSETTS UNITED STATES 02472
Legal Entity Type	Corporation
Legal Entity State	DELAWARE

Documents

Application	IMAGE/TIFF	2001-08-28
Drawing	IMAGE/TIFF	2001-08-28
Duplicate Application		2001-08-28
Duplicate Drawing		2001-08-28
XSearch Search Summary		2001-10-16
Offc Action Outgoing		2001-11-01
Paper Correspondence Incoming		2002-04-30
Response to Office Action		2002-04-30
Unclassified-Other		2002-05-15
Priority Action		2002-06-06
Fax Incoming		2002-12-06
Fax Incoming		2002-12-06
Unclassified-Other		2002-12-10
Unclassified-Other		2002-12-24
Notice of Publication		2003-04-02
Notice of Publication	APPLICATION/XML	2003-04-02
Notice of Allowance		2003-07-04
Notice of Allowance	APPLICATION/XML	2003-07-04
Notice of Allowance		2003-07-15
Fax Incoming		2004-01-13
Paper Correspondence Incoming		2004-01-15
File Jacket		2004-05-21
Intent to Use Letter		2004-06-29
Fax Outgoing		2004-07-09
ITU Extension Approval	APPLICATION/XML	2004-07-27
Notation to File		2004-07-28
Notice of Acceptance of Statement of Use		2004-09-03
Registration Certificate		2004-10-12

Attorney of Record

CHRISTINE M. BAKER
MINTZ LEVIN COHN FERRIS GLOVSKY ET AL
1 FINANCIAL CTR
BOSTON MA 02111-2621

Good, Services, and Codes

(CANCELLED)
IC 042. US 100 101. G & S: Cancer research; research and development of biopharmaceutical products, namely, vascular targeting agents and cancer therapies; and licensing of intellectual property in the field of biopharmaceutical compounds for vascular targeting agents and cancer therapies. FIRST USE: 20010829. FIRST USE IN COMMERCE: 20020201

International Codes:	42
U.S. Codes:	100,101

Type Code	Type
D10000	"THE VASCULAR TARGETING COMPANY"

Trademark Filing History

Description	Date	Proceeding Number
CANCELLED SEC. 8 (6-YR)	2011-05-13
REGISTERED-PRINCIPAL REGISTER	2004-10-12
LAW OFFICE REGISTRATION REVIEW COMPLETED	2004-08-16	76243
ASSIGNED TO LIE	2004-08-03	76243
ASSIGNED TO EXAMINER	2004-07-28	73363
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED	2004-07-28
STATEMENT OF USE PROCESSING COMPLETE	2004-07-26
SOU EXTENSION 1 GRANTED	2004-07-26
FAX SENT	2004-07-09
CASE FILE IN TICRS	2004-05-24
USE AMENDMENT FILED	2004-01-15
PAPER RECEIVED	2004-01-15
SOU EXTENSION 1 FILED	2004-01-13
FAX RECEIVED	2004-01-13
NOA MAILED - SOU REQUIRED FROM APPLICANT	2003-07-15
PUBLISHED FOR OPPOSITION	2003-04-22
NOTICE OF PUBLICATION	2003-04-02
APPROVED FOR PUB - PRINCIPAL REGISTER	2002-12-12
CORRESPONDENCE RECEIVED IN LAW OFFICE	2002-12-06
FINAL REFUSAL MAILED	2002-06-10
PAPER RECEIVED	2002-04-30
CORRESPONDENCE RECEIVED IN LAW OFFICE	2002-04-30
NON-FINAL ACTION MAILED	2001-11-02
ASSIGNED TO EXAMINER	2001-10-12	73363

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.